Search Language:

English | Use language selector above (below, on mobile) to search additional languages

See by:

open filter
  • Selected filters
  • x(Technology Companies Group)

136 items matching filters

Search Results

347020_740x360

Practice:

  • Technology Companies Group
  • Life Sciences

Blake Ilstrup Partner Technology Companies Group, Life Sciences

Seattle

Blake Ilstrup is the founding member and leader of the Technology Companies Group practice in the Pacific Northwest. His practice focuses on advising high-growth technology and life sciences companies and their investors.

Blake brings a unique and invaluable mix of in-house, entrepreneurial, and law firm experience, having served as General Counsel and senior executive of a software company and two biotech companies (co-founding one of them), as well as outside corporate counsel in elite AmLaw Global 100 law firms.

Blake’s experience spans multiple industries, including life sciences, software, hardware, mobile, fintech, cybersecurity, manufacturing, and retail. He has counseled fast-growing companies on hundreds of venture capital financings and M&A transactions, numerous public offerings, as well as service as a trusted advisor to management teams and Boards on both strategic and day-to-day matters.

Blake is proud to have worked with a variety of technology and life science companies, venture capital firms and investment banks, including AppSheet (acquired by Google; Nasdaq: GOOGL), Arris Composites, Barclays, Cloudhopper (acquired by Twitter; NYSE: TWTR), CI Security, Coatue Management, DimensionalMechanics, fatfoogoo (acquired by Digital River; Nasdaq: DRIV), Ikaria, IronPort Systems (acquired by Cisco; Nasdaq: CSCO), Kineta, KITE Solutions, Oculus (Nasdaq: FB), OncoSenX, PATH, Qpass (acquired by Amdocs; NYSE: DOX), Varian Medical (NYSE: VAR), and Zipwhip.

Prior to his legal career, Blake served with distinction in the U.S. Navy as a Surface Warfare Officer, including two combat deployments to the Persian Gulf, where he was decorated for his performance during Operations Southern Watch and Desert Strike.

8496_740x360

Practice:

  • Technology Companies Group
  • Life Sciences
  • Artificial Intelligence & Machine Learning

Scott M. Iyama Partner Technology Companies Group, Life Sciences

Silicon Valley; San Francisco

Scott Iyama is an advisor to leading technology and life science companies.  Scott provides tactical guidance throughout the life cycle of high growth companies and has led clients through hundreds of financings and numerous mergers, acquisitions, and partnering transactions.

Scott is an experienced corporate lawyer who leverages his technical experience as a member of research teams at Genentech (Virology R&D) and the NASA Ames Research Center (Advanced Displays Lab) to provide a unique business and legal perspective to companies commercializing disruptive solutions in technology and healthcare. In recognition for such work, The Recorder named Scott one of its “Lawyers on the Fast Track” (one of 50 California attorneys whose early accomplishments indicate they will be tomorrow’s leaders).

Scott has represented a majority of such companies from inception, with many of the companies founded by leading entrepreneurs and scientists from Harvard University, Stanford University, Columbia University, UC San Francisco, UC Berkeley and UCLA. He also works with non-profit entities, including the Ronald McDonald House Charities of the Bay Area.  Scott’s practice has included representation of numerous high growth companies, including:

Technology

  • Facebook
  • Instagram
  • Nervana Systems
  • Planet Labs
  • ResearchGate

Life Science/Healthcare

  • Cortexyme
  • CyberHeart
  • EpiBone
  • GRO Bioscience
  • Virta Health

Stemming from his experience and deep knowledge in the life sciences and technology industries, Scott is a frequently sought after advisor, speaker and author on technology companies. He routinely volunteers his time with entrepreneur groups and frequently lectures at forums such as the National Cancer Institute, Stanford School of Medicine, Stanford University, Stanford Technology Venture Program, the University of California, Los Angeles and the California Life Sciences Association.

347210

Practice:

  • Corporate
  • M&A and Private Equity
  • Technology Companies Group

James P. Jaconski Associate Corporate, M&A and Private Equity

New York

James Jaconski is a Corporate associate in the New York office.

His practice focuses on domestic and cross-border mergers and acquisitions, formation and equity financings for early-stage companies, and advising on corporate governance matters.
378883

Practice:

  • Technology Companies Group

Rena Kakon Associate Technology Companies Group

Paris

Réna is a member of Orrick’s Tech Companies Group.

She advises entrepreneurs and venture capital funds on equity financings, growth transactions and exits. Through the life of start-ups, Réna assists management teams to set up employees’ incentive plans, think through the governance of the company, and provide strategic and practical advice to the founders.

Réna is passionate about the transportation/mobility sector, cleantech and social impact businesses. She gained experience in these fields through her studies and work in California, France and Africa. She worked as Global Legal Counsel and Post-Merger Integration Manager of Fenix International (of ENGIE), a company developing inclusive energy and financial services for customers in frontier markets (Uganda, Zambia, Nigeria, Benin Côte d’Ivoire, Mozambique). In California, she clerked with administrative law judges at the California Public Utilities Commission and worked as a Policy Advisor on energy and climate policies for the international law firm Dentons.

Réna is taking leads on AfricaTech across the firm, and she is a member of the Automotive Tech & Mobility group.

371_740x360

Practice:

  • M&A and Private Equity
  • Technology Companies Group
  • Funds
  • Blockchain and Cryptocurrency

Larry Kane Partner M&A and Private Equity, Technology Companies Group

San Francisco

Larry Kane, a San Francisco corporate partner, represents newly formed and high growth technology companies and venture and private equity investors.  

Larry's typical representations range from  formation and early stage corporate counseling, angel and venture capital financing, mergers and acquisitions, joint ventures and partnerships to angel and venture fund formations and lending and other commercial transactions.   Larry's practice focus on a range of technology companies focused on education technology and education services, software and SAAS based businesses, consumer products to semiconductor businesses.  

16263_740x360

Practice:

  • Technology Companies Group
  • Corporate

Kevin Kearney Managing Associate Technology Companies Group, Corporate

Silicon Valley

Kevin is a managing associate in Orrick’s Technology Companies Group. He advises technology companies in various sectors and has significant experience with venture capital financings, mergers & acquisitions, debt financings and general corporate representation.

Kevin is passionate about technology and serves on the board of the “Orrick Labs” committee and is a member of Orrick’s associate technology committee.

Kevin has recently represented companies being sold in the following transactions: Wavefront to VMware; Nervana to Intel; Frame to Nutanix; AppFormix to Juniper Networks; Eat24 to GrubHub; Outward to Williams Sonoma; PernixData to Nutanix; Arkin Net to VMware; FoodyDirect to Goldbelly; BitRock to VMware.

Kevin advises high-technology businesses and venture capital investors on corporate governance, securities offerings, liquidity transactions and related matters.

8475_740x360

Practice:

  • M&A and Private Equity
  • Technology Companies Group
  • Life Sciences

Don Keller Partner M&A and Private Equity, Technology Companies Group

Silicon Valley

Don Keller, a partner in the Silicon Valley office, is a member of the Technology Companies Group.

Don advises high growth technology companies, public companies, venture capital firms and investment banks. He has advised clients on more than 60 public offerings, 75 acquisition transactions and several hundred venture financings.

Chambers USA recognized Don for his work in the areas of Venture Capital and Startups & Emerging Companies, noting he "is valued for his knowledge of venture capital firms and his strength in advising technology companies on public offerings, acquisition transactions and venture financings. One client insists that 'I would not dream of starting a company without him as my outside counsel.'" (2018)  He is ranked Band 3 for both Startups & Emerging Companies and Venture Capital (2019).

Don has held many leadership positions at Orrick. Don currently leads Orrick’s Technology and Life Sciences Sector, which is one of the three focus areas (along with energy and finance) for the firm. Don is a former member of Orrick’s Board of Directors, served as head of the firm’s global corporate practice,  served as head of the firm’s Silicon Valley Office and served as co-head of the firm's diversity efforts. 

Don also previously served for many years on the Executive Committee of Venture Law Group.

Don has recently represented companies being sold in the following transactions: Wavefront to VMware; Nervana to Intel; TOA to Oracle; Altiscale to SAP; Mainframe2 to Nutanix; Sailthru to Campaign Monitor; Twin Prime to Salesforce; 3Scale to Red Hat; Vendavo to Francisco Partners; FoodyDirect to Goldbelly; Yieldex to AppNexus; and LS9 to Renewable Energy Group.

Don has worked on transactions for Google (Nasdaq GS: GOOG), Oracle (Nasdaq GS: ORCL), Tibco (Nasdaq GS: TIBX), Adaptec (Nasdaq GS: ADPT), Shutterfly (Nasdaq GS: SFLY), Martha Stewart Living Omnimedia (NYSE:MSO), Sum Total Systems (Nasdaq GS: SUMT) and Rambus (Nasdaq GS: RMBS). He also has represented many investment banking clients in public offering transactions, including representing Goldman, Sachs & Co. in offerings for many issuers.

Don is a past member of the Board of Overseers of Boston College Law School.

375064

Practice:

  • Technology Companies Group
  • Fintech
  • Banking & Finance
  • Blockchain and Cryptocurrency
  • Energy

Rebecca Kellner Associate Technology Companies Group, Fintech

London

Rebecca is an associate in the financial services regulatory team and provides advice on a broad range of financial regulation.

Rebecca has worked with regulated companies and financial institutions on, among other things, authorisation, outsourcing, systems and controls, payment services, e-money, consumer credit and anti-money laundering regulations. She also works with clients in the Fintech space, including providing advice on crypto-currencies and ICOs.

16877_740x360

Practice:

  • Technology Companies Group
  • M&A and Private Equity
  • Corporate
  • Capital Markets
  • Blockchain and Cryptocurrency

Daniel S. Kim Partner Technology Companies Group, M&A and Private Equity

Santa Monica; Los Angeles; Orange County

Dan is a founding member of Orrick's Santa Monica Office and a partner in Orrick’s Technology Companies Group where he advises disruptive technology companies at all stages of their life cycles.

Dan has a general business and corporate law practice, representing both emerging and public companies in a variety of matters, including corporate and securities law, venture capital financings, mergers and acquisitions, day-to-day general corporate matters, structured liquidity programs, public offerings, Securities and Exchange Commission reporting and compliance and corporate governance.

Dan began his legal career in Silicon Valley and works with a significant number of clients in Southern California, the San Francisco Bay Area and around the world.  Dan is also an Adjunct Professor at Loyola Law School. 

Dan’s current and former representations include:

  • Asana
  • Beyond Meat
  • Ceradyne
  • Compellent Technologies
  • GitHub
  • Outward
  • Pinterest
  • Planet Labs
  • Spectrum Pharmaceuticals
  • ZestFinance

 Dan also has represented numerous venture capital and private equity investors including Founders Fund, Kapor Capital, Storm Ventures, Warburg Pincus, Wicklow Capital and many others.  

 Representative matters include:

VENTURE CAPITAL FINANCINGS

  • Represented Pinterest in its $150 million Series H Preferred Stock financing
  • Represented a developer of therapeutics for acute and chronic cardiovascular, and autoimmune and inflammatory diseases in its $60 million Series C Preferred Stock financing
  • Represented the lead investor in the $96 million Series D-2 Preferred Stock financing of a leading cloud provider of tax compliance automation for businesses of all sizes
  • Represented a strategic investor in the $73.5 million Series E Preferred Stock financing of a fuel-cell manufacturer
  • Represented the lead investor in a $52 million Series D Preferred Stock financing of a renewable oil and bioproducts company
  • Represented a specialty pharmaceutical company in its $45 million Series C Preferred Stock financing
  • Represented a provider of mobile marketing solutions in its $22 million Series E Preferred Stock financing
  • Represented a women’s healthcare company in its $15 million Series C Preferred Stock financing
  • Represented a data analytics company in its $15 million Series A-1 and Series A-2 Preferred Stock financing
  • Represented a provider of biological software in its $15 million Series E Preferred stock financing
  • Represented the lead investor in the $15 million Series C Preferred Stock financing of an advertising technology company
  • Represented a provider of converged cloud storage and application optimization products in its $12 million Series B Preferred Stock financing
  • Represented the lead investor in the $6.5 million Series C Preferred Stock financing of a manufacturer of devices designed to optimize rapid perfusion and clot removal in the treatment of patients suffering from ischemic stroke
  • Represented a provider of imaging solutions for the home furnishings industry in its $6.5 million Series A Preferred Stock financing
  • Represented the lead investor in the $5 million Series B Preferred Stock financing of a SaaS wellness company
  • Represented the lead investor in the $5 million Series A Preferred Stock financing of a producer of advanced cell separation tools and accessories to support regenerative medicine workflows
  • Represented dozens of other technology companies, venture capital firms, strategic investors, and angel investors in various preferred stock financings, convertible note financings and other private company capital-raising transactions.

MERGERS & ACQUISITIONS

  • Represented Planet Labs in its acquisition of Terra Bella Technologies from Google
  • Represented Yes in its sale to Twitter
  • Represented a publicly-traded, commercial-stage biotechnology company in its acquisition of a biopharmaceutical company for $45 million in cash and stock, and future earn-outs of up to $195 million
  • Represented Ceradyne in its sale to 3M Company for $860 million in an all-cash tender offer
  • Represented Compellent Technologies in its sale to Dell for $940 million
  • Represented ZestFinance in its joint venture with JD.com in China
  • Represented a managed services provider in its carve-out acquisition of the managed IT services division of a full-lifecycle spatial systems integrator
  • Represented a leading designer of mobile device accessories in its acquisition of an emerging mobile device accessories company
  • Represented a premier supplier of advanced technology products for the ruggedized electronics military market in its sale to a publicly traded, global manufacturer of aircraft products
  • Represented and successfully defended Qualstar Corporation against a hostile tender offer and defeated an activist shareholder in a proxy contest
  • Represented a private equity firm in its acquisition of a nationally branded dental laboratory and in its three follow-on acquisitions of leading dental laboratories
  • Represented a private equity firm in its acquisition of a platform chiropractic software company and in its follow-on acquisition of a leading chiropractic software company
  • Represented a portfolio company of a private equity firm in its strategic acquisition of a provider of contact center solutions and managed services
  • Represented a private equity firm in its acquisition of an independent provider of innovative communications solutions
  • Represented Cortex Pharmaceuticals in its acquisition by merger of Pier Pharmaceuticals
  • Represented a venture capital firm in its acquisition of the assets of a biopharmaceutical company in an assignment for the benefit of creditors proceeding, and in its subsequent sale of such assets to a clinical-stage, publicly traded biopharmaceutical company
  • Represented a publicly traded leader in high performance computing in its acquisition of a Japanese sales and service organization
  • Represented various other companies and institutional investors in buy-side and sell-side engagements, involving both public and private company targets and acquirers

PUBLIC OFFERINGS & PIPEs

  • Represented Beyond Meat in its initial public offering
  • Represented Silvair in its initial public offering on the Warsaw Stock Exchange (a case of first impression)
  • Represented First Foundation Inc. in its initial public offering
  • Represented underwriter Goldman, Sachs & Co. in the $98.7 million follow-on offering of InterMune
  • Represented Quark Pharmaceuticals, Inc. in its contemplated initial public offering
  • Represented Pacific Mercantile Bancorp in three secondary offerings of common stock
  • Represented Pacific Mercantile Bancorp in its $11.2 million and $26.3 million PIPE offerings
  • Represented various other issuers in follow-on offerings and PIPE offerings including XenoPort, NovaBay Pharmaceuticals, and Anesiva

 PUBLIC COMPANY REPORTING AND SEC COMPLIANCE

  • Prepared SEC filings and advised on various securities law and corporate governance matters for dozens of publicly traded companies including Anesiva, Avigen, Ceradyne, CKE Restaurants, Cortex Pharmaceuticals, Deckers Outdoor Corporation, EMCORE Corporation, NovaBay Pharmaceuticals, Pacific Mercantile Bancorp, Power Integrations, Qualstar Corporation, Spectrum Pharmaceuticals and XenoPort
395831

Practice:

  • Corporate
  • Technology Companies Group

William Lamb Managing Associate Corporate, Technology Companies Group

San Francisco

William Lamb is an associate in the San Francisco Office and a member of the firm's corporate group.

Prior to joining Orrick, William was an associate in the corporate / mergers & acquisitions practice of Hogan Lovells US LLP in Silicon Valley.

17097_740x360

Practice:

  • Corporate
  • M&A and Private Equity
  • Capital Markets
  • Corporate Governance
  • Technology Companies Group
  • Fintech

Peter M. Lamb Partner Corporate, M&A and Private Equity

Silicon Valley; Portland

Peter Lamb, a partner working across our Bay Area and Pacific Northwest offices, is a member of the Corporate Group. Peter advises private equity sponsors, technology investors, and well established private and public technology and life sciences companies.

Peter advises private equity funds and their portfolio companies on M&A and minority and majority investments. He also advises a range of mid- to late-stage private technology companies, including Aptean, Duetto Research, ESS, ProCare, Qualifacts, Sagent Lending Solutions, Stripe, Trax Retail and Zimperium. Peter regularly works with Warburg Pincus on a wide range of technology, healthcare IT and life sciences platform investments and portfolio company transactions.

Peter has also advised on the IPOs and follow-ons of numerous companies, including Cortexyme, Twist Bioscience, Elevate Financial, AVG Technologies, Pandora Media, Chegg, Portola Pharmaceuticals and ZS Pharma. His experience includes a wide range of public and private company M&A, growth equity and public market financings for tech, life sciences and private equity clients, as well as numerous cross-border buy- and sell-side M&A representations, including the $1.3 billion sale of AVG Technologies to Avast Software, and a dozen roll-up acquisitions for TA Associates and Vista Equity-backed Aptean.

351466

Practice:

  • Technology Transactions
  • IP Counseling & Due Diligence
  • Strategic Counseling
  • Corporate
  • Fintech
  • Internet of Things
  • Automotive Technology & Mobility
  • Artificial Intelligence & Machine Learning
  • Blockchain and Cryptocurrency

Amy Lauren Senior Associate Technology Transactions, IP Counseling & Due Diligence

New York

Amy Lauren, a Senior Associate in the Global Technology Transactions practice, serves as a strategic advisor to large and small companies in all stages of their development within a wide range of industries and business models. Amy helps clients understand key business and legal risks involved in efficiently managing complex legal and technology issues in connection with contract negotiations, product development and business operations. 

Amy advises clients across a spectrum of continuously innovating industries, including software licensing and development (including artificial intelligence), blockchain networks, cryptocurrency, cloud services, IoT products, online and mobile payments, intermediary products and services, wearables, fintech, e-commerce, emerging technologies, consumer products, and digital media and entertainment.

Amy was previously American Express’ lead lawyer for its digital products and strategic partnerships business and worked closely on emerging payment products in North America, Latin America and India. Prior to American Express, she spent several years in-house as a digital music attorney (including EMI Music and Warner Music), handling digital music transactions and policy, including as the global head of Digital Legal & Business Affairs at EMI Music.